December 20, 2012
(Aurora, Ontario) – Helix BioPharma Corp. (TSX, FSE: “HBP”), a biopharmaceutical company developing
drug candidates for the prevention and treatment of cancer, today announced the appointment of John A.
Rogers to the board of directors. Mr. Rogers’s appointment was effective December 18, 2012.